April 26, 2022GMA use in paediatric IBD patients: Real world experiences (in English)
The paediatric inflammatory bowel disease (IBD) can cause malnutrition and growth retardation. Patients with IBD will require life-long treatment but can be limited by the potential adverse events of corticosteroids and anti-TNF agents in children as well as secondary loss of response (LoR) and drug dependence can occur at some time during the lifetime. Experience […]
September 23, 2021Expérience de l’utilisation de l’aphérèse. Pr Guillaume Bouguen et Dr. Aurélien Amiot (French)
Source vidéo: La Lettre de L’Hépato Gastroentérologue, EDIMARK France. Source vidéo: La Lettre de L’Hépato Gastroentérologue, EDIMARK France.
September 9, 2021Pediatric patient: Does the ideal target in UC treatment exist? (in Spanish)
Unique considerations when treating children and adolescents with IBD include attention to the effects and risks of the treatments on growth and development, bone health, and psychosocial functioning. New alternatives of treatment still are needed in this context for safer and longer outcomes. The benefits of using steroids, immunosuppressants or biologics need to be carefully […]
September 8, 2021Does the ideal target in UC treatment exist?
While there is no known cure for ulcerative colitis and flare ups may recur, optimal treatment option can help patient stay in control of their disease and lead a full and rewarding life. The primary goal in treating ulcerative colitis is to help patients regulate their immune system better. Nevertheless, current approved treatments don’t work […]
Contact UsFor more informationContact Us